Indorama Ventures PCL (BKK:IVL)
Thailand
· Delayed Price · Currency is THB | Market Cap | 143.17B |
| Revenue (ttm) | 451.20B |
| Net Income (ttm) | -8.26B |
| Shares Out | 5.61B |
| EPS (ttm) | -1.47 |
| PE Ratio | n/a |
| Forward PE | 28.41 |
| Dividend | 0.70 (2.83%) |
| Ex-Dividend Date | May 5, 2026 |
| Volume | 14,106,836 |
| Average Volume | 37,626,788 |
| Open | 25.50 |
| Previous Close | 25.50 |
| Day's Range | 25.50 - 26.25 |
| 52-Week Range | 14.60 - 26.25 |
| Beta | 0.78 |
| RSI | 61.02 |
| Earnings Date | May 12, 2026 |
About Indorama Ventures PCL
Indorama Ventures Public Company Limited, together with its subsidiaries, manufactures and distributes petrochemical products in Thailand, the United States, Brazil, and internationally. It operates through four segments: Combined PET, Indovida, Indovinya, and Fibers. The Combined PET segment manufactures and distributes polyethylene terephthalate (PET) value chain comprising paraxylene, purified terephthalic acid, PET, and recycling; and specialty PET-related chemicals, such as purified isophthalic acid and naphthalene dicarboxylate. The Indov... [Read more]
Financial Performance
In 2025, Indorama Ventures PCL's revenue was 451.20 billion, a decrease of -17.07% compared to the previous year's 544.10 billion. Losses were -8.26 billion, -59.62% less than in 2024.
Financial StatementsNews
o9 Goes Live at Indorama Ventures with Integrated Business Planning Capabilities Across Global Business Segments
DALLAS--(BUSINESS WIRE)--o9, a leading software company that is powering enterprise planning and decisioning models across 30-plus industry verticals with its groundbreaking, AI-powered Digital Brain ...
Indorama Ventures PCL Transcript: CMD 2026
A leaner operating model, digitalization, and portfolio optimization underpin a plan to double EBITDA to THB 64 billion by 2028, reduce net debt by THB 68 billion, and drive free cash flow. Asset rationalizations, innovation, and a local-for-local strategy enhance resilience and growth.
Q3 2025 Indorama Ventures PCL Earnings Presentation Transcript
Q3 2025 Indorama Ventures PCL Earnings Presentation Transcript
Indorama Ventures PCL Earnings Call Transcript: Q3 2025
Q3 2025 saw continued margin pressure and weak demand, with revenue and EBITDA declining year-on-year. Management executed major cost reductions, asset rationalization, and digital transformation, while focusing on operational excellence and sustainability investments. Liquidity remains strong, but deleveraging and IPO plans are deferred amid ongoing industry headwinds.
Q2 2025 Indorama Ventures PCL Earnings Presentation Transcript
Q2 2025 Indorama Ventures PCL Earnings Presentation Transcript
Q1 2025 Indorama Ventures PCL Earnings Presentation Transcript
Q1 2025 Indorama Ventures PCL Earnings Presentation Transcript
Indorama acquires 24.9% stake in EPL
SET-listed Indorama Ventures (IVL) has acquired almost 25% of EPL, a Mumbai-based speciality packaging company, in a move to expand its footprint in emerging markets and diversify its global supply ch...
Indorama Ventures PCL Earnings Call Transcript: Q1 2025
Q1 2025 saw lower revenue and EBITDA due to global headwinds and planned maintenance, but strong cash flow enabled debt reduction. Indovinya and Fibers segments outperformed, and Q2 is expected to improve as volumes and margins recover.
Q4 2024 Indorama Ventures PCL Earnings Presentation Transcript
Q4 2024 Indorama Ventures PCL Earnings Presentation Transcript
Indorama Ventures PCL Earnings Call Transcript: Q4 2024
2024 saw improved earnings and operational resilience amid industry headwinds, with adjusted EBITDA up 10% to $1.52 billion and significant cost savings from asset rationalization. Management expects further benefits in 2025 as working capital normalizes and transformation initiatives continue.
Indorama Ventures PCL (FRA:I93) Q3 2024 Earnings Call Highlights: Strong EBITDA Growth and ...
Indorama Ventures PCL (FRA:I93) Q3 2024 Earnings Call Highlights: Strong EBITDA Growth and Strategic IPO Plans
Q3 2024 Indorama Ventures PCL Earnings Call Transcript
Q3 2024 Indorama Ventures PCL Earnings Call Transcript
Indorama Ventures PCL Earnings Call Transcript: Q3 2024
Q3 2024 saw a 32% year-on-year rise in Adjusted EBITDA to $427 million, driven by cost savings, asset rationalization, and margin recovery across all segments. Strategic initiatives, including asset sales and upcoming IPOs, are set to further reduce debt and enhance value.
Indorama Ventures PCL Earnings Call Transcript: Q2 2024
Q2 2024 saw adjusted EBITDA of $370M, strong cash flow, and major asset optimization with $666M impairment, setting up $170M annual fixed cost savings by 2025. Indovinya and Fibers rebounded, while CPET faced margin pressure but maintained premium pricing. Asset optimization and U.S. shale gas advantage are expected to drive sequential improvements.
Indorama Ventures PCL Transcript: Corporate Presentation
The company is rapidly expanding its global PET recycling capacity, targeting 1.5 million tons by 2030 and aiming for 40% circular feedstock and a 30% reduction in GHG emissions. Operational improvements, regulatory support, and strong customer partnerships are driving growth, with India and Africa as key expansion markets.